Manufacturing Industry
PFIZER INC - Research Update.
PR Newswire UK Disclose, September, 2006
Lipitor More Effective Than Simvastatin in Cutting Risk of Additional Heart
Attacks in Patients Who Had a Recent Heart Attack, New Data Suggests
* Heart Disease Patients who Were at a Very High Risk for Having a Second
Heart Attack and Took Lipitor 80mg Had a 46 Percent Reduction in the
Risk of Experiencing Additional Heart Attacks Compared With Patients
Taking Simvastatin
* Investigator: 'These data suggest the benefit of intensive treatment
with Lipitor 80mg in very high-risk heart attack patients.'
NEW YORK, Sept. 6 -- Patients who had a recent heart
attack and took Pfizer's Lipitor(R) (atorvastatin calcium) 80mg dose
experienced significantly fewer heart attacks than patients taking simvastatin
20-40mg dose,...
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
